Gastroesophageal reflux disease, or heartburn, is a common condition affecting 30% of the U.S. population and often controlled with medication
While doctors commonly recommend specific dietary and lifestyle changes to control symptoms, there is little evidence about their effectiveness
Results of this large-scale study suggest such changes, including regular exercise, can reduce symptoms substantially
This study provides evidence that common and debilitating gastrointestinal symptoms could be well controlled in many cases with diet and lifestyle modifications alone.
Andrew T. Chan, MD, MPH Chief, Clinical and Translational Epidemiology Unit Massachusetts General Hospital
BOSTON – Findings from the Nurses’ Health Study, one of the longest running studies of women’s health, show that five diet and lifestyle factors, including regular exercise, can make a significant impact on gastroesophageal reflux (GERD) or heartburn symptoms. GERD is a common condition, affecting about a third of the U.S. population; the main symptom is heartburn and it is often managed with medications. This new study suggests, however, that following diet and lifestyle guidelines may reduce symptoms substantially and could make medication unnecessary for some patients. It was published as a letter in JAMA Internal Medicine.
The five factors include normal weight, never smoking, moderate-to-vigorous physical activity for at least 30 minutes daily, restricting coffee, tea and sodas to two cups daily, and a “prudent” diet.
“This study provides evidence that common and debilitating gastrointestinal symptoms could be well controlled in many cases with diet and lifestyle modifications alone,” says Andrew T. Chan, MD, MPH, the study’s senior author. “Given that there are long-term health effects of GERD and lingering concerns about the side effects of medications used to treat it, lifestyle should be considered the best option for controlling symptoms.” Chan is a gastroenterologist, chief of the Clinical and Translational Epidemiology Unit at MGH, and professor of medicine at Harvard Medical School. The lead author of the research letter is Raaj S. Mehta, MD, gastroenterology fellow at MGH and Harvard Medical School.
The Nurses’ Health Study II is a nationwide study established in 1989 whose participants return a detailed health questionnaire twice a year. It began with 116,671 participants and has had follow-up that exceeds 90%. This study included data from almost 43,000 women aged 42 to 62 who were questioned about GERD or heartburn symptoms from 2005 to 2017 — which represents approximately 390,000 person-years.
The researchers created a statistical model that allowed them to calculate the “population-attributable risk” for GERD symptoms associated with each of the five anti-reflux lifestyle factors — in other words, they estimated how likely it was that each lifestyle factor lowered risk of experiencing symptoms. They found that following all these guidelines could reduce GERD symptoms overall by 37%. The more of the specific guidelines a woman followed, the lower her risk of symptoms. Among women using common heartburn treatments (proton pump inhibitors and H2 receptor antagonists), adhering to the guidelines also reduced symptoms.
“We were particularly interested in the effectiveness of physical activity,” says Chan. “This is one of the first studies that has demonstrated its effectiveness in controlling GERD.” This effect, he suggests, could be due in part to exercise’s effect on the motility of the digestive tract. “Being physically active may help with the clearance of stomach acid which causes heartburn symptoms,” he says.
This study was supported in part by the National Institutes of Health. About the Massachusetts General Hospital Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The Mass General Research Institute conducts the largest hospital-based research program in the nation, with annual research operations of more than $1 billion and comprises more than 9,500 researchers working across more than 30 institutes, centers and departments. In August 2020, Mass General was named #6 in the U.S. News & World Report list of "America’s Best Hospitals."
Recent headlines highlight survey findings indicating an increased risk of COVID-19 among PPI users. In this Q&A, Dr. Staller explains the COVID-19-heartburn connection, and shares his expertise on the safety of PPIs.